Both conditions are treated with fibrate drugs, which act on the peroxisome proliferator-activated receptors (PPARs), specifically PPARα, to decrease free fatty acid production. Statin drugs, especially the synthetic statins (atorvastatin and rosuvastatin), can decrease LDL levels by increasing hepatic reuptake of LDL due to increased LDL-receptor expression.
Combined hyperlipidemia
Familial hypertriglyceridemia
Familial hypercholesterolemia
types of Dyslipidemia
Hypolipoproteinemia
Hyper-CVAD
Dyslipidemia
Hyperlipidemia